Bacterial infection causing airway obstruction and cardiac complications
Neurotoxin causing severe muscle spasms — still a neonatal threat in India
3,000+ antigens — prevents both disease and transmission
Viral liver infection — risk of chronic hepatitis and liver cancer
Viral liver infection — risk of chronic hepatitis and liver cancer
Protects against all 3 types i.e. 1, 2 and 3
EasySix is not just another combination vaccine — it is a category-defining breakthrough.
Single ready-to-use fully liquid. EasySix vaccine was launched in 2017.
Open. shake. Inject. Done. Eliminates preparation errors and saves clinical time. No mixing. No risk of contamination.
Whole-cell pertussis exposes the immune system to over 3,000 bacterial antigens — building broader, more durable protection than any acellular vaccine.
DTwP + Hep B + Hib + IPV in a single 0.5 ml dose
Primary series at 6, 10, 14 weeks — complete protection in 3 visits
Fewer vials, less packaging, simpler cold chain
EasySix primary vaccination series fits into your baby's first 14 weeks — 3 visits, 6 diseases.
EasySix has a robust post-market surveillance record — continuously monitored and reported to regulatory authorities since March 2017.
Honest answers to the questions every parent deserves to ask.
About the ManufacturerSome babies may experience mild pain or tenderness at the injection site after vaccination. This is a normal and expected response — it reflects the immune system beginning to build protection. The discomfort is generally short-lived and manageable.
Fever after vaccination is the body's natural immune response to vaccine antigens. When the immune system encounters vaccine components, it activates and may produce mild fever as part of that response. This is how the body prepares to defend against infection.
Yes. Mild fever can be a normal response following vaccination and reflects the body's natural immune engagement with the vaccine antigens. It typically resolves on its own within 1–2 days. Always consult your paediatrician if you have any concerns.
Pertussis is especially dangerous for young infants because their airways are small and their immune systems are still developing. Severe coughing episodes can lead to serious complications. Infants under 6 months are at the highest risk, making early vaccination critical.
EasySix uses whole-cell pertussis (wP) technology because it contains more than 3,000 bacterial antigens — providing broader immune training than acellular vaccines, which contain only 2–5 selected antigens. This broad antigen exposure more closely resembles natural bacterial exposure and supports more comprehensive immune preparation.
Any mild discomfort following vaccination is temporary — lasting hours to a day or two. The protection built through vaccination can last years. When weighing temporary discomfort against long-term protection against six serious diseases, the benefit of vaccination is clear.
Ready-to-use liquid formulation. No reconstitution or mixing required.
EasySix has received regulatory approval and is recognised by credible health authorities for its safety and clinical performance.
Approved by Drugs Controller General of India following rigorous Phase I and Phase II/III clinical trials conducted across India
Manufactured at Panacea Biotec's WHO-GMP certified facilities — meeting the highest global standards for vaccine quality
Approved and marketed in India, Egypt and Guatemala — with regulatory submissions ongoing in additional markets
Note: WHO SAGE (November 2021) recommendation and GAVI endorsement apply to the wP-based hexavalent vaccine category.
EasySix-specific approvals are as listed above.
Per 30 million doses: 16,926,576 kg CO2 (separate schedule) vs 6,770,630 kg CO2 (EasySix)
EasySix is manufactured and marketed by Panacea Biotec —India's leading vaccine innovator with over 30 years of commitment to saving lives through science.
Learn more ➜30+ Years of innovation and care.
Supplying vaccines to 50+ countries across South Asia, Africa, Latin America and the Middle East —trusted partner to governments worldwide.
India's trusted whole-cell hexavalent vaccine.
Complete protection for complete peace of mind.